TVF deserves credit for breaking its mould of picking and sticking to favourable and comfortable genres. Space Gen could serve as a launch pad for more exciting content to come, hopes Divya Nair.
Gen Chauhan said a "whole of the nation" approach will be required to develop the shield.
An investigation into an illegal kidney racket, triggered by a farmer's complaint, has revealed a pan-India kidney transplant network involving agents, donors, doctors, and hospitals.
The US Food and Drug Administration's (USFDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars - lower-priced, near-replicas of complex biologic medicines - could significantly benefit Indian biotech companies.
The Assam government will request the Gauhati High Court to set up a fast-track court to decide on singer Zubeen Garg's death case. The cabinet also decided to appoint a special public prosecutor for the case.
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
In 2021, the Centre renamed the Rajiv Gandhi Khel Ratna as Major Dhyan Chand Khel Ratna Award. But many wonder, why despite the public sentiment the country's highest civilian honour continues to elude the man who put Indian hockey on the world map.
Bhagwat's 'retirement at age 75' comment lands just as he and Modi near that mark -- sparking whispers of retirement, rifts, and reshuffles.
Despite making immense contributions in the field of science, a Nobel prize eluded him; though he was nominated for it nine times.
The accused, Sudarshan Chandrabhan Ghule (26) and Sudhir Sangle (23), were handed over to the special investigation team of the Criminal Investigation Department (CID), which is probing the case, the official said.
'He was nominated for the Nobel Prize 9 times and several scientists wrote to the academy pointing out the injustice.' Ambassador T P Sreenivasan remembers E C G Sudarshan, the legendary physicist who passed into the ages on Monday, May 14.
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.
The prolonged delay over electing J P Nadda's successor possibly stems from the RSS leadership wanting a person who is at least equidistant from the Sangh as well as the Modi/BJP edifice, observes BJP-RSS watcher Nilanjan Mukhopadhyay.
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.
Does the Union government or the RBI see itself as Krishna beheading Shishupal and what will constitute the 101st or indeed the past many sins for which a Sudarshan Chakra will have to be used? More importantly, what are those sins?
Dr R J Rathi, the doyen of Indian chemical industry and executive chairman of Sudarshan Chemical Industries Ltd passed away in Pune Thursday after a brief illness. He was 78 years old.
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies. Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.
Banerjee is under treatment to correct her dehydration, hypoglycaeamia and other nutritional deficiencies.
'Every few days, I wake up with a sense of restlessness that time is running out'... 'We have created a due process for stressed assets to resolve, but there is no concrete plan in place for public sector bank balance sheets,' says RBI Deputy Governor Viral Acharya.
The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Outlining the wish list for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said the domestic pharma industry is currently around $50 billion in size and aspires to grow to around $130 billion by 2030 and $450 billion by 2047. "To achieve this vision, the Union Budget 2023-2024 should help fuel innovation and R&D, which will set the pace for propelling the pharmaceutical industry forward," he told PTI.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
Ek Mini Katha highlights an important body issue, but in many ways, it also trivialises it, notes Divya Nair.
Veteran doctor and educationist from Karnataka Belle Monappa Hegde and archaeology legend B B Lal were also given the Padma Vibhushan awards.
When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent.
'All these farmers and tribals were told to bring their own wood and ration to cook food during the march.'
Raiji, also a cricket historian and chartered accountant, was 13 when India played their first Test match at the Bombay Gymkhana in South Mumbai.
The fourth phase of the Lok Sabha elections will go to polls on April 29. The voting will be held for 71 seats spread across 9 states.
Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.
Rediff.com readers wish the India batting maestro on his 53rd birthday.
Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and health care webinars for salesperson's family.
Indian auto and pharma industries import several critical components and raw materials from China.
Have we been allowed to forget Partition? Isn't Partition the reason many Hindus cannot bring themselves to trust Muslims? So many Muslims born after 1947 have told me with anguish: "How long will we be blamed for Partition?" notes Jyoti Punwani.
Full list of the rejigged Union Council of Ministers
As the dust finally settles on the outcome of the Lok Sabha elections 2019 and Bharatiya Janata Party along with its NDA allies emerges as the clear winner, here is a list of who won in each of the 7 phases of elections.
Is there a likeness between the characters from Ved Vyas's timeless epic and those prancing about on the political proscenium? Saisuresh Sivaswamy finds out.
'Whatever good he did, all his achievements were overshadowed by the perception of corruption and other things.'
In the third reshuffle since coming to power, Prime Minister Modi raised the strength of his Council of Ministers from 73 to 76.
'The government says it will file a review petition against the Supreme Court, but there is no conviction here.' 'It is doing this purely because it is worried.' 'It comes from the same sentiment as asking BJP MPs to spend two nights in a Dalit village,' says Aakar Patel.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances